cyclosporine / Generic mfg. |
NCT00003661: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer |
|
|
| Completed | 2 | 3 | US | anti-thymocyte globulin, busulfan, cyclosporine, melphalan, methylprednisolone, umbilical cord blood transplantation, radiation therapy | Roswell Park Cancer Institute | Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma | 11/99 | 03/06 | | |
NCT00005641: Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation |
|
|
| Terminated | 2 | | US | anti-thymocyte globulin, busulfan, cyclophosphamide, cyclosporine, leucovorin calcium, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation, radiation therapy | H. Lee Moffitt Cancer Center and Research Institute, National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes | 09/00 | 09/00 | | |
NCT00003662: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases |
|
|
| Completed | 2 | 90 | US | anti-thymocyte globulin, busulfan, cyclophosphamide, cyclosporine, melphalan, methylprednisolone, umbilical cord blood transplantation, radiation therapy | Roswell Park Cancer Institute, National Cancer Institute (NCI) | Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Thymic Carcinoma | 01/01 | 01/01 | | |
NCT00008151: Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome |
|
|
| Completed | 2 | | US | cyclosporine, fludarabine phosphate, gemtuzumab ozogamicin, methotrexate, mycophenolate mofetil, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Leukemia, Myelodysplastic Syndromes | 07/02 | 07/02 | | |
NCT00027924: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome |
|
|
| Completed | 2 | | US | busulfan, cyclosporine, fludarabine phosphate, methotrexate, peripheral blood stem cell transplantation | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Leukemia, Myelodysplastic Syndromes | 05/03 | 05/03 | | |
NCT00016419: S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome |
|
|
| Completed | 2 | 130 | US | anti-thymocyte globulin, cyclosporine | Southwest Oncology Group, National Cancer Institute (NCI) | Leukemia, Myelodysplastic Syndromes | 07/03 | 01/07 | | |
NCT00055653: Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders |
|
|
| Completed | 2 | | US | anti-thymocyte globulin, filgrastim, busulfan, cyclophosphamide, cyclosporine, fludarabine phosphate, melphalan, methylprednisolone, umbilical cord blood transplantation, radiation therapy | Roswell Park Cancer Institute, National Heart, Lung, and Blood Institute (NHLBI) | Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic-Myeloproliferative Diseases | 09/03 | 09/05 | | |
NCT00024050: Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome |
|
|
| Completed | 2 | | US | busulfan, cyclophosphamide, cyclosporine, methotrexate, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Leukemia, Myelodysplastic Syndromes | | 08/07 | | |
NCT00003335: Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer |
|
|
| Completed | 2 | 44 | US | anti-thymocyte globulin, busulfan, cyclosporine, melphalan, methylprednisolone, umbilical cord blood transplantation, radiation therapy | Case Comprehensive Cancer Center, National Cancer Institute (NCI) | Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases | 11/07 | 01/12 | | |
NCT00281879: Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer |
|
|
| Terminated | 2 | 200 | US | anti-thymocyte globulin, ATG, filgrastim, G-CSF, busulfan, carmustine, cyclophosphamide, cyclosporine, cytarabine, etoposide, fludarabine phosphate, melphalan, methotrexate, methylprednisolone, mycophenolate mofetil, tacrolimus, FK-506, peripheral blood stem cell transplantation, umbilical cord blood transplantation, radiation therapy | OHSU Knight Cancer Institute, National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unusual Cancers of Childhood | 02/08 | 03/08 | | |
NCT00719849: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease |
|
|
| Terminated | 2 | 13 | US | anti-thymocyte globulin, cyclophosphamide, cyclosporine, fludarabine phosphate, mycophenolate mofetil, umbilical cord blood transplantation, total body irradiation | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases | 11/08 | 12/09 | | |
NCT00619645: Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers |
|
|
| Completed | 2 | 8 | US | busulfan, cyclosporine, fludarabine phosphate, mycophenolate mofetil, allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell transplantation | University of California, Davis | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes | 10/13 | 11/13 | | |
NCT00081055: OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies |
|
|
| Withdrawn | 2 | 0 | US | autologous expanded mesenchymal stem cells OTI-010, busulfan, cyclophosphamide, cyclosporine, methotrexate, peripheral blood stem cell transplantation, radiation therapy | Mesoblast International Sàrl, National Cancer Institute (NCI) | Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes | | | | |
NCT00365287: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer |
|
|
| Completed | 1/2 | 148 | NA | anti-thymocyte globulin, cyclophosphamide, cyclosporine, fludarabine phosphate, mycophenolate mofetil, radiation therapy, umbilical cord blood transplantation | Masonic Cancer Center, University of Minnesota, National Cancer Institute (NCI) | Breast Cancer, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes | 12/05 | 12/05 | | |
NCT00049634: Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder |
|
|
| Completed | 1/2 | 30 | US | busulfan, cyclophosphamide, cyclosporine, methotrexate, in vitro-treated peripheral blood stem cell transplantation | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases | 02/07 | | | |